SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-024980
Filing Date
2017-05-08
Accepted
2017-05-08 08:01:13
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v465087_10q.htm 10-Q 388367
2 EXHIBIT 31.1 v465087_ex31-1.htm EX-31.1 10116
3 EXHIBIT 31.2 v465087_ex31-2.htm EX-31.2 10069
4 EXHIBIT 32.1 v465087_ex32-1.htm EX-32.1 3882
5 EXHIBIT 32.2 v465087_ex32-2.htm EX-32.2 4000
  Complete submission text file 0001144204-17-024980.txt   3249552

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20170331.xml EX-101.INS 723801
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20170331.xsd EX-101.SCH 26973
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20170331_cal.xml EX-101.CAL 27613
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20170331_def.xml EX-101.DEF 203557
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20170331_lab.xml EX-101.LAB 244836
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20170331_pre.xml EX-101.PRE 232772
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 17820625
SIC: 2834 Pharmaceutical Preparations